Abstract
Objectives
To assess sex differences in clinical presentation, in-hospital and long-term outcome in ST-elevated myocardial infarction (STEMI) patients undergoing primary PCI (PPCI).
Background
Several studies have shown higher rates of mortality in women. These differences are not always confirmed after adjusting for confounding variables.
Methods
From January 2007 to December 2011, 325 consecutive patients (23.1% females and 76.9% males) were prospectively treated and retrospectively analyzed. Primary outcome was in-hospital and long-term mortality.
Results
Women were older (71.8 ± 11.7 vs. 62.5 ± 12.6 years; p < 0.0001), presented more renal failure (45.3% vs. 20.8%; p < 0.0001) and severe haemodynamic impairment (9.3% vs. 3.6%; p = 0.04). In-hospital overall mortality (14.7% vs. 4.8%; p = 0.003) and cardiac death (12% vs. 2%; p = 0.002) were significantly higher in women. The multivariate analysis identified age (OR 1.07; 95% CI: 1.01–1.13), resuscitated cardiac arrest (CCA) and cardiogenic shock (CS) (OR 15.31; 95% CI: 4.30–61.75), renal failure (OR 0.20; 95% CI: 0.06–0.68), but not sex (OR 1.49; 95% CI: 0.53–4.22) as independent prognostic factors of in-hospital mortality. During a median follow-up of 46.5 months (IQR range 32.7–63.1 months), long-term overall mortality (24.2% vs. 11.0%; p = 0.007) and cardiac death (4.8% vs. 1.7%; p = 0.02) were significantly higher in women. The multivariate analysis identified age (HR 1.06; 95% CI: 1.02–1.11), previous AMI (HR 3.9; 95% CI: 1.63–9.35), renal failure (HR 5.21; 95% CI: 2.12–12.85), technical success (HR 0.35; 95% CI: 0.14–0.84) but not sex (HR 0.90; 95% CI: 0.42–1.94) as independent prognostic factors of long-term mortality.
Conclusions
Worse clinical presentation rather than sex may explain the excess of mortality in women with STEMI undergoing PPCI.
Highlights
- •
Women presented higher in-hospital and long-term mortality and MACE rates;
- •
After adjustment gender is not an independent predictor of worse prognosis;
- •
Females showed older age, higher rates of renal failure and hemodynamic impairment.
1
Introduction
Cardiovascular diseases are the leading cause of death in Europe both for men and women, accounting for over 4 million deaths each year . The highest cluster of risk consists of patients affected by acute ST segment elevation myocardial infarction (STEMI) , but it’s still subject of debate if there is any prognostic difference between women and men . Several studies have shown that women exhibit higher rates of mortality and worse risk profiles .
Conversely, in some series, differences in mortality rates were no longer present after adjustment for age and other risk factors . Moreover, only a limited number of studies reported medium or long term mortality results .
Differences in inclusion criteria (i.e. whole acute coronary syndrome spectrum or only the STEMI subset) and in treatment strategies (i.e. medical or interventional) might unfold some different results.
The aim of the present study was to assess sex differences in clinical presentation, hospital management, short and long term outcomes in a retrospective cohort of STEMI patients undergoing primary PCI.